Cited by 98Metabolism, Diabetes, and CancerAdipose Tissue and MetabolismMitochondrial Function and Pathology

Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels

Open access
Anedda, Andrea, Rial, Eduardo, González-Barroso, M Mar·2008·Journal of Endocrinology

Abstract

Metformin is a drug widely used to treat type 2 diabetes. It enhances insulin sensitivity by improving glucose utilization in tissues like liver or muscle. Metformin inhibits respiration, and the decrease in cellular energy activates the AMP-activated protein kinase that in turn switches on catabolic pathways. Moreover, metformin increases lipolysis and β-oxidation in white adipose tissue, thereby reducing the triglyceride stores. The uncoupling proteins (UCPs) are transporters that lower the efficiency of mitochondrial oxidative phosphorylation. UCP2 is thought to protect against oxidative stress although, alternatively, it could play an energy dissipation role. The aim of this work was to analyse the involvement of UCP2 on the effects of metformin in white adipocytes. We studied the effect of this drug in differentiating 3T3-L1 adipocytes and found that metformin causes oxidative stress since it increases the levels of reactive oxygen species (ROS) and lowers the aconitase activity. Variations in UCP2 protein levels parallel those of ROS. Metformin also increases lipolysis in these cells although only when the levels of ROS and UCP2 have decreased. Hence, UCP2 does not appear to be needed to facilitate fatty acid oxidation. Furthermore, treatment of C57BL/6 mice with metformin also augmented the levels of UCP2 in epididymal white adipose tissue. We conclude that metformin treatment leads to the overexpression of UCP2 in adipocytes to minimize the oxidative stress that is probably due to the inhibition of respiration caused by the drug.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1677/joe-08-0278

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Metformin has been proposed to cause a mild and transient inhibition of mitochondrial complex I which decreases ATP levels and activates AMPK-dependent catabolic pathways, increasing lipolysis and beta-oxidation in white adipose tissue and reducing neoglucogenesis.

    “Metformin has been proposed to cause a mild and transient inhibition of mitochondrial complex I which decreases ATP levels and activates AMPK-dependent catabolic pathways [100], increasing lipolysis and ß-oxidation in white adipose tissue [102] and reducing neoglucogenesis [2].”
  • Metformin can upregulate uncoupled proteins 2 in adipose tissue and can cause an increase in reduced glutathione.

    “It can upregulate uncoupled proteins 2 (UCP2) in adipose tissue [102] and can also cause an increase in reduced glutathione [100].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Ahima RS & Flier JS 2000 Leptin. Annual Review of Physiology 62 413-437.
  2. Bailey CJ, Path MRC & Turner RC 1996 Metformin. New England Journal of Medicine 334 574-579.
  3. Wieland O 1974 Glycerol UV method. In Methods of Enzymatic Analysis, pp 1404-1409. Ed. HU Bergmeyer. London: Academic Press.

Cited by

Sorted by citations

Authors
Anedda, A., Rial, E., & González-Barroso, M. M.
Affiliations
Consejo Superior de Investigaciones Científicas (ES)
Venue
Journal of Endocrinology
Published
2008-08-07
Volume
199
Issue
1
Pages
33-40
ISSN
  • 0022-0795 (ISSN-L)
  • 1479-6805
OpenAlex
W2162039295
Cited by
98
References
48
Citations by year
2026: 2 · 2025: 2 · 2024: 9 · 2023: 6 · 2022: 3 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 5 · 2017: 7 · 2016: 8 · 2015: 10 · 2014: 4 · 2013: 6 · 2012: 7
FWCI
1.92
Type
journal article
Language
en
Open access
Locations
  • Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
Funders
  • Ministerio de Ciencia e Innovación (CSD2007-00020, BFU2006-08182)
  • Regione Autonoma della Sardegna
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
metformin, UCP2, oxidative stress, white adipocytes, reactive oxygen species, aconitase activity, lipolysis, fatty acid oxidation, mitochondrial respiration inhibition, AMPK, type 2 diabetes, 3T3-L1 adipocytes, epididymal adipose tissue
MeSH terms
Uncoupling Protein 2, Animals, Cell Differentiation, Gene Expression Regulation, Hypoglycemic Agents, Ion Channels, Lipolysis, Metformin, Mice, Inbred C57BL, Blotting, Western, Oxidative Stress, Mitochondrial Proteins, 3T3-L1 Cells, Mice, Adipose Tissue, White, Adipocytes, White, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review